» Download Public Reports
About 700 reports
- Company report
- March 2013
- 10 pages
March 2013
... Assessment of risk and appropriate preventative steps should be undertaken as outlined in the Guidelines for the management of absolute cardiovascular disease risk (National vascular disease prevention ...
May 2013
... For patients with mild to severe sleep disorders. Air liquide intends to pursue healthy sleep solutions Development by favouring the continuity of the company S management, led by marjan mikel and stephen ...
March 2013
... Commercial and licensing deals. In addition, we view diabetic nephropathy program and future partnerships in molecular diagnostics as an upside to our current target price, with strong ip around midkine ...
April 2013
... Formulated diclofenac by thermis. Top international stories positive data from vertex S cystic fibrosis drug:- boston-based vertex pharmaceuticals has reported positive data from a phase-2 clinical trial ...
February 2013
... To hepatitis c included with hiv 3rd national hiv/aids strategy partnerships in practice - 1996 hepatitis c did not have foundation community sector which was active in hiv as a function ...
April 2013
... There is much more to do, and we are determined to save as many lives as we can in our quest to beat cardiovascular disease australia S leading cause of, death. For all hearts Is the new strategy for 2013 ...
March 2013
... In the 25-35 year old age group a recent analysis of the national cancer institute statistic showed that survival rates have not increased at all since 1975 cancer is the leading disease killer ...
» Purchase Premium Reports
(From $ 125 - $ 3 995)
About 100 reports
- $ 3 995
- Industry report
- May 2013
- by Global Data
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an ...
May 2013
$ 3 500
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer's Disease Summary ...
March 2013
$ 300
Summary Norgine Limited (Norgine) is a pharmaceutical company, based in Netherlands. It operates through the development, manufacturing and marketing sectors of pharmaceutical products. Norgine's key products ...
March 2013
$ 300
Summary Mesoblast Limited (Mesoblast) is a biotechnology company, based in Australia. It operates through the development of biological products for regenerative medicines. Mesoblast is specialized in ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
